Multiple sclerosis (MS) is a lifelong disease that causes growing disability and significant challenges for patients, carers, and health systems. Every five minutes, someone is diagnosed, and three million people live with MS worldwide. MS frequently affects people at the height of their working and family-building years. Our research captures this multi-faceted burden of disability through economic modeling and a new survey of neurologists, assessing how MS is measured and managed across seven countries to expose gaps and spotlight best practices.

Whitepaper

Explore the survey results capturing neurologists’ views and experiences with measuring and managing MS-related disability, and our analysis of the economic impact of MS-related disability across France, Germany, Italy, Spain, Sweden, the UK and the US.

Download

Country analysis

United States

75% of neurologists in the US report that a more comprehensive approach is needed to measure disability for people living with MS.

Download infographic
Germany

54% of neurologists in Germany report concerns about the ability of existing measurement tools to detect disability progression.

Download infographic
Spain

More than 40% of MS multidisciplinary teams lack access to mental healthcare and occupational therapy.

Download infographic
Italy

Over 95% of people with MS in Italy experience fatigue, but only 35% of neurologists assess this symptom.

Download infographic
France

Over 80% of MS multidisciplinary teams in France do not provide access to sexual and reproductive healthcare.

Download infographic
Sweden

54% of neurologists in Sweden report concerns about a lack of staff/resources to support comprehensive assessments of disability.

Download infographic
United Kingdom

66% of neurologists in the UK report that there is insufficient time during appointments to administer standardised measures of disability.

Download infographic

Articles

Card one image | Sanofi

The quiet crisis of MS

How subtle “smouldering” symptoms are reshaping our understanding of the disease.

Advertisement feature

The hidden reality

The real impact of neurological disease.

Advertisement feature

Event